YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

Two-day-old baby KJ Muldoon only had a few months left to live. Diagnosed with a rare and fatal genetic disease, his life hung in the balance — the only known treatment offering little hope of ...